Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation

Experimental Dermatology

Volumn 23, Issue 9, 2014, Pages 670-676

  Strozyk, Elwira A ^a   Desch, Anna ^b   Poeppelmann, Birgit ^c   Magnolo, Nina ^c   Wegener, Joachim ^d   Huck, Volker ^b   Schneider, Stefan W ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INST OF REPRO MED OF THE UNIV   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ADAMTS13; IL 6; Melanoma; Tissue factor; VWF

Indexed keywords

CYTOKINE; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

BIOLOGICAL MODEL; CALCIUM SIGNALING; CAPILLARY PERMEABILITY; DISEASE COURSE; HUMAN; INFLAMMATION; MELANOMA; METABOLISM; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

CALCIUM SIGNALING; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; CYTOKINES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MELANOMA; MODELS, BIOLOGICAL; NF-KAPPA B; PHENOTYPE; THROMBOPLASTIN; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 84921916428     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12505     Document Type: Article

References (63)

1. Miller A J, Mihm M C Jr. N Engl J Med 2006: 355: 51-65.
2. Gray-Schopfer V, Wellbrock C, Marais R. Nature 2007: 445: 851-857.
3. Tas F. J Oncol 2012: 2012: 647684.
4. Riechers A, Bosserhoff A K. Exp Dermatol 2014: 23: 12-14.
5. Hodi F S, O'Day S J, McDermott D F et al. N Engl J Med 2010: 363: 711-723.
6. Flaherty K T, McArthur G. Cancer 2010: 116: 4902-4913.
7. McKee C S, Hill D S, Redfern C P et al. Exp Dermatol 2013: 22: 767-769.
8. Gelot P, Dutartre H, Khammari A et al. Exp Dermatol 2013: 22: 297-298.
9. Kakkar A K. Best Pract Res Clin Haematol 2009: 22: 147-151.
10. Rickles F R, Shoji M, Abe K. Int J Hematol 2001: 73: 145-150.
11. Kerk N, Strozyk E A, Poppelmann B et al. J Invest Dermatol 2010: 130: 2259-2268.
12. Desch A, Strozyk E A, Bauer A T et al. Am J Pathol 2012: 181: 693-705.
13. Goerge T, Barg A, Schnaeker E M et al. Cancer Res 2006: 66: 7766-7774.
14. Goerge T, Kleineruschkamp F, Barg A et al. Thromb Haemost 2007: 98: 283-286.
15. Pappelbaum K I, Gorzelanny C, Grassle S et al. Circulation 2013: 128: 50-59.
16. Petri B, Broermann A, Li H et al. Blood 2010: 116: 4712-4719.
17. Hillgruber C, Steingraeber A K, Poppelmann B et al. Exp Dermatol 2013: 22: E9 Meeting Abstract.
18. Morganti M, Carpi A, Amo-Takyi B et al. Biomed Pharmacother 2000: 54: 431-436.
19. Fallah M A, Myles V M, Kruger T et al. Biomicrofluidics 2010: 4: 024106-10.
20. Tao Z, Wang Y, Choi H et al. Blood 2005: 106: 141-143.
21. Levy G G, Nichols W C, Lian E C et al. Nature 2001: 413: 488-494.
22. Crawley J T, Lam J K, Rance J B et al. Blood 2005: 105: 1085-1093.
23. Bockmeyer C L, Claus R A, Budde U et al. Haematologica 2008: 93: 137-140.
24. Morioka C, Uemura M, Matsuyama T et al. Scand J Gastroenterol 2008: 43: 1387-1396.
25. Ishikawa M, Uemura M, Matsuyama T et al. Alcohol Clin Exp Res 2010: 34(Suppl 1): S25-S33.
26. Bernardo A, Ball C, Nolasco L et al. Blood 2004: 104: 100-106.
27. Levi M, van der Poll T, Buller H R. Circulation 2004: 109: 2698-2704.
28. Moretti S, Chiarugi A, Semplici F et al. Melanoma Res 2001: 11: 395-399.
29. Guida M, Riccobon A, Biasco G et al. Melanoma Res 2006: 16: 317-323.
30. Soubrane C, Rixe O, Meric J B et al. Melanoma Res 2005: 15: 199-204.
31. Barisic S, Strozyk E, Peters N et al. Cell Death Differ 2008: 15: 1681-1690.
32. Burrows F J, Haskard D O, Hart I R et al. Cancer Res 1991: 51: 4768-4775.
33. Wallbrecht K, Drick N, Hund A C et al. Exp Dermatol 2011: 20: 980-985.
34. Okahara H, Yagita H, Miyake K et al. Cancer Res 1994: 54: 3233-3236.
35. Schadendorf D, Heidel J, Gawlik C et al. J Natl Cancer Inst 1995: 87: 366-371.
36. Vidal-Vanaclocha F, Fantuzzi G, Mendoza L et al. Proc Natl Acad Sci U S A 2000: 97: 734-739.
37. Satyamoorthy K, DeJesus E, Linnenbach A J et al. Melanoma Res 1997: 7(Suppl 2): S35-S42.
38. van Muijen G N, Jansen K F, Cornelissen I M et al. Int J Cancer 1991: 48: 85-91.
39. Van Muijen G N, Cornelissen L M, Jansen C F et al. Clin Exp Metastasis 1991: 9: 259-272.
40. Strozyk E, Poppelmann B, Schwarz T et al. Oncogene 2006: 25: 6239-6251.
41. Schumacher D, Strilic B, Sivaraj K K et al. Cancer Cell 2013: 24: 130-137.
42. Keese C R, Bhawe K, Wegener J et al. Biotechniques 2002: 33: 842-844, 846, 848-850.
43. Kashani-Sabet M, Shaikh L, Miller J R 3rd et al. J Clin Oncol 2004: 22: 617-623.
44. Kashani-Sabet M, Liu Y, Fong S et al. Proc Natl Acad Sci U S A 2002: 99: 3878-3883.
45. Lorigan P, Eisen T, Hauschild A. Exp Dermatol 2008: 17: 383-394.
46. Rao C, Bui T, Connelly M et al. Int J Oncol 2011: 38: 755-760.
47. Ireland A, Millward M, Pearce R et al. Clin Exp Metastasis 2011: 28: 327-336.
48. Nieswandt B, Hafner M, Echtenacher B et al. Cancer Res 1999: 59: 1295-1300.
49. Maraveyas A, Johnson M J, Xiao Y P et al. Cancer Metastasis Rev 2010: 29: 777-784.
50. Pendu R, Terraube V, Christophe O D et al. Blood 2006: 108: 3746-3752.
51. Huang J, Roth R, Heuser J E et al. Blood 2009: 113: 1589-1597.
52. Hillgruber C, Steingraber A K, Poppelmann B et al. J Invest Dermatol 2014: 134: 77-86.
53. Klarenbach S W, Chipiuk A, Nelson R C et al. Circ Res 2003: 92: 272-278.
54. Bogatcheva N V, Garcia J G, Verin A D. Biochemistry (Mosc) 2002: 67: 75-84.
55. Elias E G, Hasskamp J H, Sharma B K. Cancers (Basel) 2010: 2: 794-808.
56. Qin Y, Ekmekcioglu S, Liu P et al. Mol Cancer Res 2011: 9: 1537-1550.
57. Carmi Y, Dotan S, Rider P et al. J Immunol 2013: 190: 3500-3509.
58. Khalili J S, Liu S, Rodriguez-Cruz T G et al. Clin Cancer Res 2012: 18: 5329-5340.
59. Pazyar N, Feily A, Yaghoobi R. Curr Clin Pharmacol 2012: 7: 271-275.
60. Klemke M, Weschenfelder T, Konstandin M H et al. J Cell Physiol 2007: 212: 368-374.
61. Coupland L A, Chong B H, Parish C R. Cancer Res 2012: 72: 4662-4671.
62. Ludwig R J, Boehme B, Podda M et al. Cancer Res 2004: 64: 2743-2750.
63. Surapisitchat J, Hoefen R J, Pi X et al. Proc Natl Acad Sci U S A 2001: 98: 6476-6481.